Cargando…

Outcomes of ischemic stroke in patients with atrial fibrillation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Patients with atrial fibrillation (AF) have higher risk of ischemic stroke. PURPOSE: We investigated whether AF patients experiencing an ischemic stroke have worse outcomes. METHODS: AF patients admitted to the stroke unit from 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Marrese, A, Meola, M, Fonderico, C, Salucci, A, Comparone, G, Pergola, V, Faccenda, D, Addeo, L, Cocchiara, L, Ammirati, G, Rapacciuolo, A, Strisciuglio, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207390/
http://dx.doi.org/10.1093/europace/euad122.218
_version_ 1785046442246668288
author Marrese, A
Meola, M
Fonderico, C
Salucci, A
Comparone, G
Pergola, V
Faccenda, D
Addeo, L
Cocchiara, L
Ammirati, G
Rapacciuolo, A
Strisciuglio, T
author_facet Marrese, A
Meola, M
Fonderico, C
Salucci, A
Comparone, G
Pergola, V
Faccenda, D
Addeo, L
Cocchiara, L
Ammirati, G
Rapacciuolo, A
Strisciuglio, T
author_sort Marrese, A
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Patients with atrial fibrillation (AF) have higher risk of ischemic stroke. PURPOSE: We investigated whether AF patients experiencing an ischemic stroke have worse outcomes. METHODS: AF patients admitted to the stroke unit from 2018 to 2021 were included. The NIHSS and the modified Rankin Scale (mRS) score were calculated at the admission and at discharge. The neurological improvement was calculated as delta NIHSS (NIHSS at admission - NIHSS at discharge =Δdis). RESULTS: Six-hundred patients (45% men), mean age 69±13 years. Of these 75 had previous history of atrial fibrillation (AF) and 86 had AF during the hospitalization (46 both). Overall 115 had one of the two. Patients with AF had higher NIHSSad (14.5±7 vs 9.6±7; p<0.001) and NIHSS24 (10.4±8 vs 7.2±7; p<0.001) than patients without, however the neurological improvement was greater (Δdis -8.4±8 vs -5.1±6; p=0.004), indeed the NIHSSdis was similar (5.6±7 vs 4.1±6; p=0.1). Patients with AF also had a more impaired mRS before the ischemic event and at discharge (1.34±1.3 vs 0.58±1.1, p<0.001; 2.6±1.7 vs 1.8±1.9, p=0.005). Amongst AF patients with CHADVASC³2 in men and ³3 in women, 36% of them were taking antiplatelet therapy, 35% anticoagulants and 29% didn’t take any therapy. Of interest, no differences in the NIHSSad nor in the NIHSSdis were found between them and neither in the Δdis. As for the treatment of AF patients, patients who underwent to mechanical thrombectomy (MT) had higher NIHSSad (17± 5) compared to patients receiving intravenous thrombolysis (IV) or nothing (11± 7 and 12± 8) (p<0.001). The NIHSSdis was similar between the three groups however the Δdis was significantly higher in patients treated with mechanical thrombectomy (-12.5±6 vs 3.6±4; vs 3.1±8; p=0.003 and p<0.001 respectively). CONCLUSIONS: Patients with AF experience more severe stroke, however the neurological recovery is greater than in patients without the arrhythmia. The treatment with antiplatelets or anticoagulants before the event does not reduce the severity of the stroke and does not influence the improvement of the NIHSS at discharge. The mechanical thrombectomy is more effective in reducing the neurological impairment.
format Online
Article
Text
id pubmed-10207390
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102073902023-05-25 Outcomes of ischemic stroke in patients with atrial fibrillation Marrese, A Meola, M Fonderico, C Salucci, A Comparone, G Pergola, V Faccenda, D Addeo, L Cocchiara, L Ammirati, G Rapacciuolo, A Strisciuglio, T Europace 10.6 - Stroke Treatment FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Patients with atrial fibrillation (AF) have higher risk of ischemic stroke. PURPOSE: We investigated whether AF patients experiencing an ischemic stroke have worse outcomes. METHODS: AF patients admitted to the stroke unit from 2018 to 2021 were included. The NIHSS and the modified Rankin Scale (mRS) score were calculated at the admission and at discharge. The neurological improvement was calculated as delta NIHSS (NIHSS at admission - NIHSS at discharge =Δdis). RESULTS: Six-hundred patients (45% men), mean age 69±13 years. Of these 75 had previous history of atrial fibrillation (AF) and 86 had AF during the hospitalization (46 both). Overall 115 had one of the two. Patients with AF had higher NIHSSad (14.5±7 vs 9.6±7; p<0.001) and NIHSS24 (10.4±8 vs 7.2±7; p<0.001) than patients without, however the neurological improvement was greater (Δdis -8.4±8 vs -5.1±6; p=0.004), indeed the NIHSSdis was similar (5.6±7 vs 4.1±6; p=0.1). Patients with AF also had a more impaired mRS before the ischemic event and at discharge (1.34±1.3 vs 0.58±1.1, p<0.001; 2.6±1.7 vs 1.8±1.9, p=0.005). Amongst AF patients with CHADVASC³2 in men and ³3 in women, 36% of them were taking antiplatelet therapy, 35% anticoagulants and 29% didn’t take any therapy. Of interest, no differences in the NIHSSad nor in the NIHSSdis were found between them and neither in the Δdis. As for the treatment of AF patients, patients who underwent to mechanical thrombectomy (MT) had higher NIHSSad (17± 5) compared to patients receiving intravenous thrombolysis (IV) or nothing (11± 7 and 12± 8) (p<0.001). The NIHSSdis was similar between the three groups however the Δdis was significantly higher in patients treated with mechanical thrombectomy (-12.5±6 vs 3.6±4; vs 3.1±8; p=0.003 and p<0.001 respectively). CONCLUSIONS: Patients with AF experience more severe stroke, however the neurological recovery is greater than in patients without the arrhythmia. The treatment with antiplatelets or anticoagulants before the event does not reduce the severity of the stroke and does not influence the improvement of the NIHSS at discharge. The mechanical thrombectomy is more effective in reducing the neurological impairment. Oxford University Press 2023-05-24 /pmc/articles/PMC10207390/ http://dx.doi.org/10.1093/europace/euad122.218 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.6 - Stroke Treatment
Marrese, A
Meola, M
Fonderico, C
Salucci, A
Comparone, G
Pergola, V
Faccenda, D
Addeo, L
Cocchiara, L
Ammirati, G
Rapacciuolo, A
Strisciuglio, T
Outcomes of ischemic stroke in patients with atrial fibrillation
title Outcomes of ischemic stroke in patients with atrial fibrillation
title_full Outcomes of ischemic stroke in patients with atrial fibrillation
title_fullStr Outcomes of ischemic stroke in patients with atrial fibrillation
title_full_unstemmed Outcomes of ischemic stroke in patients with atrial fibrillation
title_short Outcomes of ischemic stroke in patients with atrial fibrillation
title_sort outcomes of ischemic stroke in patients with atrial fibrillation
topic 10.6 - Stroke Treatment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207390/
http://dx.doi.org/10.1093/europace/euad122.218
work_keys_str_mv AT marresea outcomesofischemicstrokeinpatientswithatrialfibrillation
AT meolam outcomesofischemicstrokeinpatientswithatrialfibrillation
AT fondericoc outcomesofischemicstrokeinpatientswithatrialfibrillation
AT saluccia outcomesofischemicstrokeinpatientswithatrialfibrillation
AT comparoneg outcomesofischemicstrokeinpatientswithatrialfibrillation
AT pergolav outcomesofischemicstrokeinpatientswithatrialfibrillation
AT faccendad outcomesofischemicstrokeinpatientswithatrialfibrillation
AT addeol outcomesofischemicstrokeinpatientswithatrialfibrillation
AT cocchiaral outcomesofischemicstrokeinpatientswithatrialfibrillation
AT ammiratig outcomesofischemicstrokeinpatientswithatrialfibrillation
AT rapacciuoloa outcomesofischemicstrokeinpatientswithatrialfibrillation
AT strisciugliot outcomesofischemicstrokeinpatientswithatrialfibrillation